Insider Trading March 12, 2026

Cerus CFO Discloses $169,646 in Share Sales, Also Buys Additional Stock

Kevin D. Green executed multiple sales and an on‑market acquisition as Cerus reports stronger-than-expected Q4 2025 revenue

By Maya Rios CERS
Cerus CFO Discloses $169,646 in Share Sales, Also Buys Additional Stock
CERS

Cerus Corp (NASDAQ: CERS) Chief Financial Officer Kevin Dennis Green sold 83,021 shares of common stock across March 5 and 6, 2026, bringing proceeds of roughly $169,646, while also acquiring 63,854 shares on March 5. The stock has fallen about 12% over the past week and was trading at $1.79 at the time of the report. Separately, Cerus reported fourth-quarter 2025 revenue of $233.8 million, a 16% year-over-year increase, with EPS of -$0.01 in line with analyst estimates.

Key Points

  • Cerus CFO Kevin Dennis Green sold 83,021 shares on March 5-6, 2026, for approximately $169,646 with sale prices ranging from $2.0055 to $2.17.
  • Green also acquired 63,854 shares on March 5 and now directly holds 1,168,095 shares of Cerus common stock.
  • Cerus reported Q4 2025 revenue of $233.8 million, a 16% year-over-year increase, and EPS of -$0.01, in line with analyst expectations.

Cerus Corp (NASDAQ: CERS) disclosed insider activity by its chief financial officer, Kevin Dennis Green, who sold a total of 83,021 shares of common stock in transactions executed on March 5 and March 6, 2026. The combined proceeds from those sales amounted to approximately $169,646. Prices on the sell transactions ranged from $2.0055 to $2.17 per share.

Details of the disposition show that on March 5 Green sold 55,225 shares in multiple trades, with execution prices between $2.015 and $2.17 per share. The following day, March 6, he sold an additional 27,796 shares at a weighted average price of $2.0055.

In the same reporting period, Green also purchased 63,854 shares of Cerus common stock on March 5. After accounting for the sales and purchase, Green's direct ownership in Cerus stands at 1,168,095 shares.

The insider transactions occurred as Cerus shares have moved lower in recent trading - the stock declined roughly 12% over the prior week and was quoted at $1.79 at the time of this report. According to an InvestingPro analysis cited in company-related commentary, the shares appear undervalued at current levels, with that platform offering subscribers detailed analysis on the firm’s financial position and a Fair Value assessment.


Financial results announced for the fourth quarter of 2025 show Cerus produced revenues of $233.8 million, representing a 16% increase versus the same quarter a year earlier. That top-line strength exceeded market projections. On a per-share basis the company reported earnings of -$0.01, which matched analyst expectations.

Company commentary around the results highlights steady revenue growth and continuing execution of strategic initiatives. The stock was reported to be stable during after-hours trading following the release. Market participants and analysts are continuing to track Cerus’ performance as revenue growth and near-term profitability indicators evolve.


Investors assessing the context of Green’s activity will note the combination of sales and a concurrent purchase, and the broader corporate update that includes the Q4 2025 results. Additional market intelligence tools, including InvestingPro and ProPicks products, are referenced by market participants as means to evaluate valuation, fundamentals and relative opportunities across the sector.

This article provides a record of the disclosed insider trades and the company’s recent quarterly financials for readers monitoring insider activity, valuation signals and revenue momentum.

Risks

  • Share-price volatility - the stock declined about 12% over the past week and was trading at $1.79, which can affect market sentiment and liquidity for holders.
  • Interpreting insider transactions - simultaneous sales and purchases by an executive can be difficult to interpret and may not clearly signal confidence or concern.
  • Reliance on valuation tools - assertions that the stock is undervalued come from third-party analysis (InvestingPro), and subscribers should consider the limitations of platform-based Fair Value assessments.

More from Insider Trading

Bankwell Financial Director Adds 10,000 Shares in $466K Purchase Mar 12, 2026 Immunome Director Adds 2,000 Shares as Company Secures $400M Financing and Prices Public Offering Mar 12, 2026 Vistra EVP Executes $1.6M Stock Sale; Company Posts Mixed Quarter Mar 12, 2026 nLIGHT CEO Disposes of $1.12M in Shares as Stock Nears 52-Week Peak Mar 12, 2026 Reddit CTO Completes $1.29M Share Sale, Exercises Options and Donates Large Block of Stock Mar 12, 2026